发明申请
US20080234273A1 Heteroaryl Benzamide Derivatives for Use as Glk Activators in the Treatment of Diabetes
审中-公开
用作糖尿病治疗中的Glk激活剂的杂芳基苯甲酰胺衍生物
- 专利标题： Heteroaryl Benzamide Derivatives for Use as Glk Activators in the Treatment of Diabetes
- 专利标题（中）： 用作糖尿病治疗中的Glk激活剂的杂芳基苯甲酰胺衍生物
-
申请号： US11995079申请日： 2006-06-03
-
公开(公告)号： US20080234273A1公开(公告)日： 2008-09-25
- 发明人: Darren McKerrecher , Kurt Gordon Pike , Michael James Waring
- 申请人： Darren McKerrecher , Kurt Gordon Pike , Michael James Waring
- 优先权： GB0514174.2 20050709; GB0516298.7 20050809
- 国际申请： PCT/GB2006/002472 WO 20060603
- 主分类号： C07D277/38
- IPC分类号： C07D277/38 ; A61K31/426 ; A61K31/428 ; C07D285/135 ; A61K31/433 ; A61K31/44 ; C07D213/72 ; C07D401/04 ; A61K31/454 ; A61K31/505 ; C07D239/42 ; A61K31/4965 ; C07D241/20 ; C07D403/14 ; C07D403/02 ; C07D237/20 ; A61K31/50 ; A61K31/415 ; C07D231/38 ; C07D413/04 ; A61K31/5377 ; A61K31/496 ; C07D417/00 ; A61P3/10
摘要：
Compounds of formula (I) wherein R1, R2, R3, and HET-1 are as described in the specification, and their salts, are activators of glucokinase (GLK) and are thereby useful in the treatment of for example, type 2 diabetes. Processes for preparing compounds of formula (I) are also described.
信息查询
